Automation of biochip array technology for quality results.

Area of Science:

• Biotechnology
• Proteomics
• Assay Development

Background:

• Proteomics demands simultaneous measurement of multiple markers, achievable with biochip array technology.
• Current laboratory practices often involve manual biochip fabrication and testing, necessitating standardization.
• Ensuring reproducibility in biochip processes is crucial for accurate results and understanding complex protein relationships in diseases.

Purpose of the Study:

• To present novel control checks and standardization methods for biochip fabrication and analysis.
• To demonstrate the performance of the Evidence analyser in biochip processes.
• To ensure the quality and reproducibility of multi-marker assays.

Main Methods:

• Implementation of novel control checks in biochip fabrication, reagent manufacture, automation, and imaging for the Evidence analyser.
• Utilization of reference spots for precise localization and simultaneous quantification of multiple markers.
• Presentation of performance and standardization methodologies.

Main Results:

• Dispense solution formulation directly impacts the shape, stability, and integrity of test regions on biochips.
• Assays for fertility hormones and drugs of abuse exhibited excellent precision and stability.
• Results showed strong comparability with other commercial methods.

Conclusions:

• Control processes in the manufacture and analysis of Evidence components guarantee assay reproducibility.
• The developed methods ensure reliable quantification of both routine and novel markers.
• Standardized biochip technology provides a robust tool for proteomic analysis.